Comment on Kanis et al.: "European guidance for the diagnosis and management of osteoporosis in postmenopausal women".
Clausen
J O
JO
D050071:Bone Density Conservation Agents / Q000493:pharmacokinetics*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000493:pharmacokinetics*; D019379:Teriparatide / Q000493:pharmacokinetics*; D013810:Therapeutic Equivalency
D050071:Bone Density Conservation Agents; D010281:Parathyroid Hormone; D019379:Teriparatide